News | November 14, 2022
Ionis, Metagenomi pen Big Pharma-sized genetic target pact that could total almost $3B
Read More
Press Release | November 7, 2022
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
Read More
Press Release | October 11, 2022
DICE Therapeutics Announces Positive Topline Data from Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for Psoriasis
Read More
Press Release | October 3, 2022
Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies
Read More
